Clinical Studies of Interventions to Mitigate Cardiovascular Risk in Peritoneal Dialysis Patients

Dev Jegatheesan1, Yeoungjee Cho2, David W Johnson2

  • 1Department of Nephrology, Princess Alexandra Hospital, Brisbane, Australia; School of Medicine, University of Queensland, Brisbane, Australia.

Insights

Cardiovascular disease (CVD) is a major concern for peritoneal dialysis (PD) patients, significantly increasing mortality risk. Addressing traditional, kidney-related, and PD-specific factors is crucial for mitigating CVD in this population.

Area of Science:

  • Nephrology
  • Cardiology
  • Public Health

Background:

  • Cardiovascular disease (CVD) affects up to 60% of patients undergoing peritoneal dialysis (PD).
  • CVD is the leading cause of death in PD patients, with mortality rates 10-20 times higher than the general population.
  • Risk factors for CVD in PD patients are multifactorial, including traditional, kidney disease-related, and PD-specific elements.

Purpose of the Study:

  • To review evidence on cardiovascular interventions targeting modifiable risk factors in PD patients.
  • To highlight key recommendations from the International Society for Peritoneal Dialysis (ISPD) Cardiovascular and Metabolic Guidelines.
  • To inform clinical practice and improve cardiovascular outcomes in the PD population.

Main Methods:

  • Literature review of studies on CVD risk factors and interventions in PD patients.
  • Analysis of traditional risk factors (hypertension, dyslipidemia, obesity, etc.).
  • Evaluation of nontraditional (anemia, inflammation, etc.) and PD-specific (dialysis solutions, etc.) risk factors.

Main Results:

  • PD patients face elevated risks from a combination of traditional, kidney disease-related, and PD-specific factors.
  • While interventions targeting these factors show promise, high-level clinical evidence is often limited.
  • ISPD guidelines offer recommendations for managing cardiovascular risk in PD.

Conclusions:

  • Comprehensive management of diverse risk factors is essential for reducing CVD in PD patients.
  • Further research is needed to establish high-level evidence for cardiovascular interventions in this population.
  • Adherence to ISPD guidelines can help optimize cardiovascular care for PD patients.

Related Concept Videos

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications01:25

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
870
Peritoneal Dialysis I: Introduction and Procedure01:30

Peritoneal Dialysis I: Introduction and Procedure

Peritoneal dialysis (PD) is a procedure that facilitates the exchange of solutes, waste products, electrolytes, and excess fluid between the blood in the peritoneal capillaries and a dialysis solution introduced into the peritoneal cavity.Principles of Peritoneal Dialysis (PD)Diffusion: Waste products such as urea and electrolytes move from high concentrations in the blood to low concentrations in the dialysate across the peritoneal membrane. This mechanism is driven by the concentration...
3.4K
Peritoneal Dialysis III: Nursing Management01:25

Peritoneal Dialysis III: Nursing Management

Peritoneal dialysis, or PD, utilizes the peritoneal membrane as a filter to eliminate excess fluid and waste products. Effective nursing management is essential for ensuring patient safety, preventing complications, and promoting optimal function of the peritoneal dialysis process.Assessment and MonitoringNurses must thoroughly assess the patient before, during, and after each dialysis session. Regular monitoring includes vital signs, daily weight, fluid intake and output, and laboratory values...
899
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis01:30

Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis

Patients with end-stage renal disease (ESRD) or those experiencing drug overdose often require extracorporeal methods to eliminate accumulated drugs and metabolites. Hemoperfusion, hemofiltration, and dialysis are the primary techniques to rapidly remove harmful substances without disrupting the patient's fluid and electrolyte balance. For those with compromised renal function, dosage adjustments of concurrent medications may be necessary during extracorporeal drug removal.Dialysis is a process...
546
Dialysis01:27

Dialysis

Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
1.5K
Dialysis01:15

Dialysis

Dialysis is a diffusion-based purification process that separates analyte molecules from a complex matrix. This is accomplished by allowing molecules in the solution to pass through a semipermeable membrane into a liquid on the other side. The membrane is usually made of cellulose acetate or cellulose nitrate, and the second liquid must be miscible with the solution. Ions (e.g., chloride or sodium) or organic molecules (e.g., glucose) can pass through the membrane pores, which generally have...
1.9K